title: Choosing a hypomethylating agent in MDS: does gender matter?
authors.affiliation: a Service d'Hématologie, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Université Paris Diderot, Paris, France ; Paris , France.
authors.forename: Matthieu
authors.initials: M
authors.lastname: Duchmann
authors.affiliation: b Service d'Hématologie Adultes , Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Université Paris Diderot , Paris , France.|c CNRS/INSERM UMR 7212/944 , Paris , France.
authors.forename: Raphael
authors.initials: R
authors.lastname: Itzykson
mesh_terms: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine; D006801:Humans; D009190:Myelodysplastic Syndromes
chemical_list: D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine